Cargando…
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry
OBJECTIVE: Cholinesterase inhibitors (ChEIs) and memantine are the only approved pharmacological treatments for Alzheimer’s disease (AD). Recent literature suggests reductions in cardiovascular burden and risk of stroke in ChEI users. However, the clinical effectiveness of these drugs in patients wi...
Autores principales: | Secnik, Juraj, Schwertner, Emilia, Alvarsson, Michael, Hammar, Niklas, Fastbom, Johan, Winblad, Bengt, Garcia-Ptacek, Sara, Religa, Dorota, Eriksdotter, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039592/ https://www.ncbi.nlm.nih.gov/pubmed/31958305 http://dx.doi.org/10.1136/bmjdrc-2019-000833 |
Ejemplares similares
-
Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of ∼130,000 Swedish Subjects over 14 Years
por: Secnik, Juraj, et al.
Publicado: (2020) -
TREATMENT WITH ANTIPSYCHOTICS AND RISK OF DEATH IN 58,000 PATIENTS FROM SWEDISH DEMENTIA REGISTRY
por: Religa, Dorota, et al.
Publicado: (2019) -
Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia
por: Secnik, Juraj, et al.
Publicado: (2022) -
Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry
por: Secnik, Juraj, et al.
Publicado: (2017) -
The association of antidiabetic medications and Mini-Mental State Examination scores in patients with diabetes and dementia
por: Secnik, Juraj, et al.
Publicado: (2021)